Multiple Ascending Dose Study of BMS-777607 in Subjects With Advanced or Metastatic Solid Tumors
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
Part A: The purpose of this study is to find the maximum tolerated dose of BMS-777607 in
subjects with advanced or metastatic solid tumors
Part B: The purpose of this study is to describe the preliminary activity of BMS-77607 in
subjects with advanced or metastatic gastroesophageal cancer, hormone refractory prostate
cancer, head and neck squamous cell carcinoma, and type I papillary renal cell carcinoma